(5-METHYL-3-(7-MORPHOLIN-4-YL-5-(3-PHENYLPYRAZOL-1-YL)PYRAZOLO(1,5-A)PYRIMIDIN-2-YL)PYRAZOL-1-YL)METHYL (2S)-2-AMINO-3-METHYLBUTANOATE
UNII 2R89V3P8Z4
Substance Identification & Data
This profile provides standardized clinical and technical data for (5-methyl-3-(7-morpholin-4-yl-5-(3-phenylpyrazol-1-yl)pyrazolo(1,5-a)pyrimidin-2-yl)pyrazol-1-yl)methyl (2s)-2-amino-3-methylbutanoate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 2R89V3P8Z4.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3053720-90-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C29H33N9O3 GUJMBUTUROHRQF-NDEPHWFRSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for (5-methyl-3-(7-morpholin-4-yl-5-(3-phenylpyrazol-1-yl)pyrazolo(1,5-a)pyrimidin-2-yl)pyrazol-1-yl)methyl (2s)-2-amino-3-methylbutanoate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.